

Credit: Unsplash
A bipartisan coalition of federal lawmakers has expressed serious concerns over Meta’s handling of illicit drug advertisements on its platforms, Facebook and Instagram. In a letter sent to Meta CEO Mark Zuckerberg on Thursday, the lawmakers demanded answers about the company’s efforts to curb such ads, which have been linked to sales of prescription pills, cocaine, and other recreational drugs.
The letter cites recent investigations by The Wall Street Journal and the nonprofit Tech Transparency Project, revealing a significant number of ads that direct users to third-party services selling illegal substances. “On March 16, 2024, the Wall Street Journal reported that U.S. federal prosecutors have been investigating Meta for facilitating the sale of illicit drugs,” the lawmakers noted. They pointed out that despite this investigation, new reports on July 31, 2024, indicated that Meta continued to host ads directing users to online marketplaces for illegal drugs.
The 19 lawmakers, including Reps. Tim Walberg (R-Mich.), Gus Bilirakis (R-Fla.), Kathy Castor (D-Fla.), and Lori Trahan (D-Mass.), expressed their alarm over Meta’s ongoing issues with ad moderation. They criticized the company for approving and monetizing these ads, which were easily accessible and contained explicit references to illegal drugs. The lawmakers highlighted that despite Meta’s claims of sophisticated ad targeting and personalization, its internal processes appear to have failed in detecting and removing such content.
In their letter, the lawmakers posed 15 questions to Zuckerberg, seeking detailed information on how Meta plans to address the problem. They have requested a response by September 6, 2024.
Meta has acknowledged receipt of the letter and plans to provide a detailed response. The company reiterated its commitment to combating illegal drug activity, stating, “Drug dealers are criminals who work across platforms and communities, which is why we work with law enforcement to help combat this activity. Our systems are designed to proactively detect and enforce against violating content, and we reject hundreds of thousands of ads for violating our drug policies.”
Meta emphasized its continued investment in improving enforcement measures and expressed empathy for those affected by the ongoing drug epidemic, noting that it requires a collective effort to address effectively.
As scrutiny intensifies, Meta faces mounting pressure to demonstrate its effectiveness in combating illicit content on its platforms and ensuring the safety of its users.
-
Elon Musk’s AI company, xAI, is reportedly gearing up to launch a stand-alone consumer app that could shake up...
-
Generative AI is no longer just about creating content. As these powerful tools become more accessible, businesses are finding...
-
Amazon shares surged 6% on Friday following the company’s release of strong quarterly earnings, exceeding market expectations. Boosted by...
-
Shares of Trump Media surged by as much as 19% on Tuesday, marking the fourth consecutive day of gains...
-
Amazon is doubling down on its revolutionary cashierless technology, “Just Walk Out,” after pulling it from most of its...
-
The cryptocurrency market experienced a significant rally on Thursday, just one day after the Federal Reserve made the surprise...
-
Another Year, Another iPhone! Apple has announced a big event on September 9 at its headquarters in Cupertino, California....
-
Turkey’s recent suspension of Instagram has sparked significant controversy, with Human Rights Watch (HRW) condemning the move as a...
-
Former President Donald Trump addressed the annual Bitcoin Conference in Nashville on Saturday, outlining his stance on the future...
-
Apple Inc. has reached an agreement with EU antitrust regulators to open up its mobile payments technology to competitors,...
-
Meta, the parent company of Facebook, is under scrutiny from the European Commission for allegedly breaching EU antitrust regulations...
-
OpenAI is pleased to announce the addition of Paul M. Nakasone, a retired U.S. Army general and former director...